Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications/contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications/contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute, Special Emphasis Panel; 3D Human Tissue Culture Systems.
Date: June 14, 2016.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 2E032/034, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Reed A. Graves, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W264, Bethesda, MD 20892-9750, 240-276-6384, gravesr@mail.nih.gov.
Name of Committee: National Cancer Institute, Special Emphasis Panel; R13 Conference Grants Review.
Date: June 14, 2016.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W556, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Bratin K. Saha, Ph.D. Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W556, Bethesda, MD 20892-9750, 240-276-6411, sahab@mail.nih.gov.
Name of Committee: National Cancer Institute, Special Emphasis Panel; NCI Research Specialist Award—3.
Date: June 16-17, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center 5701 Marinelli Road Bethesda, MD 20852.
Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review Officer, Special Review Branch, Division Of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W242, Bethesda, MD 20892-9750, 240-276-6372, zouzhiq@nih.gov.
Name of Committee: National Cancer Institute, Special Emphasis Panel; Genomic Data Analysis Network (U24).
Date: June 17, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Ritz-Carlton Hotel, Tysons Corner, 1700 Tysons Boulevard, McLean, VA 22102.
Contact Person: Dona Love, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W236, Rockville, MD 20892-9750, 240-276-5264, donalove@mail.nih.gov.
Name of Committee: National Cancer Institute, Special Emphasis Panel; NCI R03 SEP-3.
Date: June 20-21, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott, Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Thomas A. Winters, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W412, Bethesda, MD 20892-9750, 240-276-6386, twinters@mail.nih.gov.
Name of Committee: National Cancer Institute, Special Emphasis Panel; NCI Omnibus R03 SEP-1.
Date: June 23-24, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda 8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Denise L. Stredrick, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W640, Bethesda, MD 20892-9750, 240-276-5264, stredrid@mail.nih.gov.
Name of Committee: National Cancer Institute, Special Emphasis Panel; NCI Research Specialist Award—2 (R50).
Date: June 23-24, 2016.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency, Bethesda One, Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Viatcheslav A. Soldatenkov, MD, Ph.D. Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-6378, soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer Institute, Special Emphasis Panel; Assay Validation for High Quality Markers for NCI-Supported Clinical Trials (UH2/UH3)
Date: June 23, 2016.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W264, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Reed A. Graves, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W264, Bethesda, MD 20892-9750, 240-276-6384, gravesr@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Epidemiology Studies: Childhood Cancer Survivors and Core Infrastructure and Methodology Research.
Date: June 24, 2016.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W108, Bethesda, MD 20892-9750, 240-276-6343, schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Omnibus R03 SEP—1.
Date: June 28-29, 2016.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Cambria Suites Rockville, 1 Helen Heneghan Way, Rockville, MD 20850.
Contact Person: Jennifer C. Schiltz, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W624, Bethesda, MD 20892-9750, 240-276-5864, jennifer.schiltz@mail.nih.gov
Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Detection, Diagnosis, and Treatment Technologies for Global Health.
Date: June 29, 2016.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 4W030, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Gerard Lacourciere, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W248, Bethesda, MD 20892-9750, 240-276-5457, gerard.lacourciere@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; Innovative Research in Cancer Nanotechnology.
Date: July 21, 2016.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 3E030, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Gerard Lacourciere, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W248, Bethesda, MD 20892-9750, 240-276-5457, gerard.lacourciere@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)
Dated: May 10, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-11395 Filed 5-13-16; 8:45 am]
BILLING CODE 4140-01-P